MPM Oncology Impact Management LP, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 86,670 shares at $20.88 ($1.8M) on 2021-05-28, disclosed to the SEC on 2021-06-02.
Open-market sale of $1.8M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.88 | 10,685 | $223K | 12.5% |
| 2 | $20.88 | 10,685 | $223K | 12.5% |
| 3 | $21.92 | 3,100 | $68K | 3.8% |
| 4 | $22.60 | 100 | $2K | 0.1% |
| 5 | $20.44 | 18,491 | $378K | 21.1% |
| 6 | $20.44 | 18,491 |
| $378K |
| 21.1% |
| 7 | $20.50 | 25,118 | $515K | 28.8% |
| Total | $20.62 avg | 86,670 | $1.8M | 100% |
| Filing → |
| ITOS | SELL | 2021-04-13 | $6K | — | Filing → |
| ITOS | SELL | 2021-04-09 | $2.5M | — | Filing → |
| CGEM | BUY | 2021-01-14 | $6.3M | — | Filing → |